MSIM embodied AI supplement supports controlled worksite adoption as the base case; consumer humanoids are later-stage.
Reports
Extracted robotics reports: synthesis layer
This page turns the three approved finance workspace notes into source-backed signals. PDF-derived claims remain secondary unless traced to filings, company pages or official releases.
Updated 2026-06-15. Evidence map only; no trade recommendation.
What changes the dashboard
Humanoid 100 improves the market-expression map without becoming a buy list or valuation conclusion.
Track source-traced 22 DoF/forearm-actuator claims, actual output, yield, accepted units and factory deployment KPI.
Track prospectus-backed revenue, product mix, shipments, humanoid margin, customer mix and support cost.
Source-note extraction cards
MS Q3 PDF supplements
robotics-q3-ms-pdf-supplements-2026-06-15.md
PDF extracts display
robotics-pdf-extracts-display-2026-06-15.md
Unitree IPO Q3 deep dive
robotics-unitree-ipo-q3-deep-dive-2026-06-15.md
Source discipline
Optimus Gen 3, hand teardown, Figure/Tesla comparison, MSIM EDGE and Humanoid 100 remain secondary extracted material.
Unitree financial anchors now use the prospectus extract rather than older secondary memo values.
Several-trillion / $60tn-style frames stay as context only until tied to value capture, margins and repeat deployment.